Pharmaceutical Science III - HIV (Dr. Lee)

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/57

encourage image

There's no tags or description

Looks like no tags are added yet.

58 Terms

1
New cards

what are viruses

intracellular parasites that need a host to survive

2
New cards

AIDs is caused by

HIV

3
New cards

Tx of HIV infection

highly active antiretroviral therapy (HAART)

4
New cards

PEP

post exposure prevention
- occupational, needle stick, blood or mucus exposure

-non occupational, mother to infant, and sex

5
New cards

PrEP

pre-exposure prevention
- those with ongoing high risk

6
New cards

PrEP: truvada

emtricitabine + tenofovir disoproxil
2012

7
New cards

PrEP

emtricitabine + tenofovir alafenamide
2019
men and transgender women

8
New cards

HIV Life cycle

binding/fusion with host CD4 cells
reverse transcriptase
integration
transcription
virion assembly
budding

9
New cards

HIV binds and enter ___ cells

CD4

10
New cards

what was the 1st HIV agent

zidovudine 1987

11
New cards

antiviral classes

entry inhibitors
NRTI
NNRTI
protease inhibitors
integrase inhibitors

12
New cards

nucleoside

base + sugar

13
New cards

nucleotide

base + sugar + phosphate

14
New cards

what was the new drug in 2022

lenacapavir
capsid inhibitor

15
New cards

how does HIV enter host cell

virus binds to cd4 receptor on T cell
gp120/cd4 complex significant changes
gp120 binds to CCR5 more changes
exposure of gp120 fusion of viral envelop in host cell

16
New cards

entry inhibitor: maraviroc

binds to CCR5 on T cell

17
New cards

entry inhibitor: enfuvirtide 2003

binds to gp41 to prevent fusion of virus and cell membrane

used for advanced drug resistance

NO ACTIVITY AGAISNT HIV-2

18
New cards

entry inhibitor: ibalizumab- uiyk 2018

binds to cd4 domain 2

used for multidrug resistant HIV-1

19
New cards

entry inhibitor: fostemsavir 2020

binds to gp120

tx multidrug resistant HIV-1

20
New cards

NRTI

lack 3-0H grp

stop DNA chain growth

21
New cards

Toxic NRTI

zidovudine
stavudine
didanosine

22
New cards

less toxic NRTI

tenofovir
lamivudine
emtricitabine
abacavir *HLB 5701

23
New cards

T/F NRTI cause mitochondrial toxicity; Lactic acidosis, peripheral neuropathy, hepatic steatosis, pancreatitis, lipoatrophy

true

24
New cards

what is the most common S/E for zidovudine

myelosuppression
anemia
neutropenia

25
New cards

didanosine S/E

dose limiting peripheral neuropathy

26
New cards

what drug also treats HBV but not recommended anymore

lamivudine

27
New cards

which NRTI is potent monotherapy for HBV

tenofovir

28
New cards

what inhibits HBV and HIV reverse transcriptase

emtricitabine

29
New cards

2 NRTI 1 PI

NRTI
tenofovir
emtricitabine

PI
ritonavir
darunavir

30
New cards

2 NRTI 1 Integrase Inhibitor

NRTS
tenofovir
emtricitabine

Integrase inhibitor
raltegravir
dolutegravir
elvietgravir

31
New cards

NNRTI

non-competitive
adjacent to active site inducing conformation change

32
New cards

NNRTI drugs

Efavirenz
Nevirapine
Etravirine
Rilpivirine
Doravirine

33
New cards

which NNRTIs are a potent inducer of CYP450

efavirenz
nevirapine
etravirine

34
New cards

NNRTI: efavirenz

S/E
CNS clouding
teratogenic

35
New cards

which NNRTI is used in pts who've never taken HIV drugs

doravirine

fixed dose Delstrigo

36
New cards

Protease inhibitor drugs

-navir

atazanavir
darunavir
fosamprenavir
indinavir
lopinavir
nelfinavir
ritonavir
saquinavir
tipranavir

37
New cards

PI moa

block post translational maturation of viral proteinds

38
New cards

which PI is metabolic booster and CYP450 inhibitor

ritonavir

39
New cards

t/f all PI are substrates for CYP34A

true

40
New cards

PI S/E

hyperglycemia
hypertriglyceridemia
hypercholesterolemia

41
New cards

integrase inhibitors

- gravir

Raltegravir
Elvitegravir
Dolutegravir
Bictegravir
carnotegravir

42
New cards

which drug does not have antiviral activity and inhibits CYP450

cobicistat

43
New cards

cd4 cells

lymphocyte T cells that detect intruders

44
New cards

CD4 cell count of uninfected/healthy person

500-1,600 cells/mm3

45
New cards

CD4 cell count of stage 3 AIDS

< 200 cells/mm3

46
New cards

what is used to determine when ART therapy needs to start

CD4 count

47
New cards

HAART regimens

2 NRTI + 1 NNRTI/PI/INSTI

48
New cards

preferred regimens HAART

tenofovir/emtricitabine + raltegravir
tenofovir/emtricitabine + dolutegravir
abacavir/lamivudine + dolutegravir (HLB 5701 -)
tenofovir/emtricitabine + elvitegravir + cobicistat (good kidney function)
tenofovir/emtricitabine + ritonavir + darunavir

49
New cards

a 28 year old male homosexual graduate student is newly diagnosed with HIV. His CD4 count is 720 cell/mm3 and his viral load is 33, copies. would you start him on a ART therapy?

YES

50
New cards

which regimen would you recommend as 1st line

a/ abacavir/lamivudine/dolutegravir
b/ emtricitabine/tenofovir/efavirenz
c/ abacavir/tenofovir/lamivudine
d/ emtricitabine/tenofovir/maraviroc

a/ abacavir/lamivudine/dolutegravir

51
New cards

a patient who tested + for HIV arrives at clinic with fever, nonreproductive cough, and fatigue. CD4 count is 184 cell/mm3. What is findings

a/ patient has AIDS
b/ patient in latent stages of HIV
c/ patient tested + for HIV

a/ patient has AIDS

52
New cards

moa for maraviroc

a/ prevents virus entry
b/ cellular membrane of virus disrupted
c/ viral synthesis disrupted

a/ prevents virus entry

53
New cards

PI that inhibits CYO3A4 and combined with other PI to reduce pill numbers

a/ didanosine
b/ delviridine
c/ efavirenz
d/ ritonavir

d/ ritonavir

54
New cards

lopinavir + ritonavir + zidovudine plus ___

a/ atazanavir
b/ efavirenz
c/ lamivudine
d/ nevirapine

c/ lamivudine

55
New cards

one should not combine stavudine with ___

a/ atazanavir
b/ zidovudine
c/ lamivudine

b/ zidovudine

56
New cards

S/E for PI

a/ insulin resistance/hyperlipidemia
b/ lactic acidosis
c/ pancreatitis
d/ peripheral neuropathy

a/ insulin resistance/hyperlipidemia

57
New cards

NRTI have peripheral neuropathy, pancreatitis, myopathy, cardiomyopathy and lactic acidosis is ___

mitochondrial toxicity

58
New cards

a drug that inhibits reverse transcriptase, but does not require intracellular activation and binds to different site on RT

nevirapine